PRKAA2 and neoplasm: In contrast, tumour cells with glycolytic phenotype can enhance mitochondrial metabolism (such as the absorption of glutamine and activation of AMPK); its real purpose is to avoid excessive tumour cell death events during migration (such as anti-anoikis by activation of AMPK).